Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
DYT4 type primary dystonia is characterized by predominantly laryngeal dystonia (manifesting as whispering dysphonia) and cervical dystonia (manifesting as torticollis).
Features include common findings: Torticollis and Dysphonia; and sometimes findings: Difficulty swallowing (dysphagia), Limb dystonia, and Hemidystonia. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Difficulty swallowing (dysphagia), Limb dystonia, Gait ataxia |
Head and neck | 1 | Narrow face |
Digestive system | 1 | Difficulty swallowing (dysphagia) |
Arms and legs | 1 | Limb dystonia |
TUBB4A-related neurologic disorders have a heterogeneous presentation and represent a spectrum of disease. Two primary phenotypes have emerged, TUBB4A-related leukodystrophy and DYT-TUBB4A (previously called DYT4 dystonia). TUBB4A-related leukodystrophy typically presents in childhood; age of onset ranges from a few months in more severe forms to later childhood or adulthood in some instances of isolated hypomyelination . The disorder is progressive and the rate of progression varies with disease severity. DYT-TUBB4A, formerly known as whispering dysphonia, is a rare cause of isolated dystonia that ranges from mild to severe with onset from early childhood to the third decade of life. While spasmodic dysphonia and/or craniocervical dystonia are often the presenting signs, progression to limbs and/or generalized dystonia is common . Laryngeal dystonia is the most common feature, present in more than three quarters of affected individuals . Brain MRI is typically normal. To date, at least 200 individuals have been identified with a pathogenic variant in TUBB4A . The following description of the phenotypic features associated with this condition is based on these reports. Table 2. TUBB4A-Related Neurologic Disorders: Comparison of Clinical Manifestations Clinical Manifestations | Frequency of Neurologic Findings TUBB4A-related leukodystrophy1 | DYT-TUBB4A2
Neurodevelopmental delays | 95% | 0% |
|---|---|---|
Loss of motor abilities (incl independent assisted ambulation) | 50% | Loss of ability can occur in setting of severe generalized dystonia. |
A peculiar gait dystonia called "hobby horse" gait has been described . Pyramidal involvement |
TUBB4A function has not been fully characterized.
Torsion dystonia 4 is associated with mutations in the TUBB4A gene on chromosome 19.
The penetrance of TUBB4A-related neurologic disorders is not known to date and may differ by phenotypic presentation. Penetrance appears to be 100% in TUBB4A-related leukodystrophy, while there are reports of reduced penetrance in DYT-TUBB4A .
Source: GeneReviews — "TUBB4A-Related Neurologic Disorders"
No consensus clinical diagnostic criteria for TUBB4A-related neurologic disorders have been published to date.
TUBB4A-related neurologic disorders should be suspected in individuals with the following clinical and brain imaging findings and family history. Neurologic and neurodevelopmental features variably reported in affected individuals include:
Neurodevelopmental delays
Including motor and speech-language delays
Range from mild delays to severe neurodevelopmental impairment with limited acquisition of motor or cognitive milestones
Abnormal movements including focal, multifocal, or generalized dystonia, with both fixed and mobile features.
Source: GeneReviews — "TUBB4A-Related Neurologic Disorders"
TUBB4A-related leukodystrophy. Hypomyelinating leukodystrophies with early childhood onset and/or movement disorders should be considered in the differential diagnosis . Table 3. TUBB4A-Related Leukodystrophy: Genetic Differential Diagnosis
Gene(s) | Disorder | MOI | Brain MRI Findings | Features Similar to TUBB4A-Related Leukodystrophy | Features Distinct from TUBB4A-Related Leukodystrophy |
|---|---|---|---|---|---|
Pelizaeus-Merzbacher-like disease 1 | AR | Diffuse homogeneous hyperintense T2-weighted signal affecting WM of cerebrum cerebellum; Involvement of corticospinal tracts w/abnormal T2-weighted signal extending into brain stem resulting in extensive brain stem involvement; Thin CC in older children |
Genetic testing for TUBB4A is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for torsion dystonia 4. The disease remains an area of unmet medical need.
Standard of care guidelines have been proposed for TUBB4A-related leukodystrophy .
To establish the extent of disease and needs in an individual diagnosed with TUBB4A-related neurologic disorders, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
TUBB4A-Related Neurologic Disorders: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
Constitutional
| Assessment of overall growth incl weight, height, head circumference | Assessment of head circumference recommended for head growth abnormalities.
| By pediatric neurologist/ developmental pediatrician (pediatric) radiologist | • Baseline brain MRI for leukodystrophy /or structural abnormalities
Eval for tone abnormalities incl spasticity
EEG consideration of initiation of appropriate ASMs if seizures are a concern1
Eval for movement disorders or abnormal movements incl dystonia tremor
Assessment of gross fine motor skills language cognitive development
Assessment for behavioral disorders
| Developmental assessment | • To include motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Orthopedics/ physical medicine rehab/ PT OT eval | To include assessment of:
Source: GeneReviews — "TUBB4A-Related Neurologic Disorders"
View trials for torsion dystonia 4
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. TUBB4A-Related Neurologic Disorders: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Psychiatric | Assessment for anxiety, ADHD, ASD, aggression, self-injury | At least annually Musculoskeletal |
Ophthalmologic involvement | Routine ophthalmology eval | Per treating ophthalmologist(s) Low vision services |
Cardiovascular | Cardiovascular eval | Per treating cardiologist Electrocardiogram |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; OT = occupational therapy; PT = physical therapy |
Source: GeneReviews — "TUBB4A-Related Neurologic Disorders"
Phenotype severity distribution: 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for torsion dystonia 4.
5 publications have been identified in PubMed for torsion dystonia 4. Research spans Basic Science / Preclinical (40%), Epidemiology / Natural History (40%), and Case Report / Case Series (20%).
Gao Q (2026). [PMID: 41534472](https://pubmed.ncbi.nlm.nih.gov/41534472/). *The Journal of pharmacology and experimental therapeutics*. [Basic Science / Preclinical]
Keritam O (2025). [PMID: 40415656](https://pubmed.ncbi.nlm.nih.gov/40415656/). *Movement disorders : official journal of the Movement Disorder Society*. [Case Report / Case Series]
Doquenia MLM (2024). [PMID: 39400991](https://pubmed.ncbi.nlm.nih.gov/39400991/). *Movement disorders clinical practice*. [Epidemiology / Natural History]
Wu R (2024). [PMID: 38845987](https://pubmed.ncbi.nlm.nih.gov/38845987/). *Heliyon*. [Epidemiology / Natural History]
Pan K (2024). [PMID: 38123503](https://pubmed.ncbi.nlm.nih.gov/38123503/). *The European journal of neuroscience*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
45% |
0% |
Spasmodic dysphonia/dysarthria | 0% | 90% |
Feeding difficulties (incl dysphagia) | 45% | Occasional |
Musculoskeletal complications (incl scoliosis) | 40% | Occasional after long-standing dystonia |
Cerebellar signs | 20%-30% | 0% |
Movement disorders | 20%-30% | 100% (dystonia; can be focal, multifocal, or generalized) |
Abnormal eye movements (incl nystagmus) | 30% | 0% |
Epilepsy | 30% | 0% |
Autonomic dysfunction | 25% | 0% 1. Neurodevelopmental delays. Some affected children have a period of normal motor development with subsequent deterioration . |
Source: GeneReviews — "TUBB4A-Related Neurologic Disorders"
— |
— |
— |
Brain atrophy ventricular dilatation | Usually presents during early childhood w/manifestations similar to those of H-ABC phenotype incl: DD, speech delay, pyramidal extrapyramidal involvement, cerebellar signs, preservation of mental functions | Affected children manifest w/nystagmus early in disease course, which – although it has been described in TUBB4A-related LD – is not typical. | — | — | — |
PLP1 | Pelizaeus-Merzbacher disease (PMD) (See PLP1 Disorders.) | XL | Diffuse hypomyelination; No isolated cerebellar basal ganglia atrophy | — | — |
Global atrophy may be seen in older persons. | Typically presents during infancy or early childhood w/combination of nystagmus, upper motor neuron dysfunction, gait ataxia, extrapyramidal signs | POLR3A POLR3B POLR1C | — | — | — |
POLR3-related leukodystrophy | AR | Hypomyelinating leukodystrophy pattern characterized by T2 mild hyperintensity of WM T1 hyperintensity, isointensity, or mild hypointensity of WM when compared w/gray matter structures | — | — | — |
Variably present: cerebellar atrophy thinning of CC. | Manifestations include spasticity, gait ataxia, extrapyramidal movement disorders, cerebellar signs. | Abnormal dentition hypogonadotropic hypogonadism | — | — | — |
SLC17A5 | Salla disease (See Free Sialic Acid Storage Disorders.) | AR | Hypomyelination, incl basal ganglia | — | — |
Hypoplasia of CC | Progressive neurologic deterioration w/spasticity, extrapyramidal movement disorders, seizures | Coarse facial features, bone malformations, behavioral characteristics (e.g., aggressive behavior) | — | — | — |
SOX10 | Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, Hirschsprung disease (PCWH) (OMIM 609136) | AD | Diffuse WM abnormalities cerebral atrophy | DD, spasticity, gait ataxia, extrapyramidal movement disorders | Involvement of PNS (sensory loss); Waardenburg syndrome (skin hair pigmentation changes, heterochromia iridis, hearing loss); Hirschsprung disease TUBA1A TUBB TUBB2A TUBB2B TUBB3 TUBG1 |
Tubulinopathies | AD | Spectrum of abnormalities incl cortical malformations (ranging from PMG to cortical dysplasia), WM abnormalities, callosal agenesis, brain stem cerebellar abnormalities incl cerebellar hypoplasia | ... | — | — |
Source: GeneReviews — "TUBB4A-Related Neurologic Disorders"